200 related articles for article (PubMed ID: 32378712)
21. Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy.
Corsini EM; Foo WC; Mitchell KG; Zhou N; Maru DM; Ajani JA; Hofstetter WL; ; Correa AM; Antonoff MB; Lin SH; Mehran RJ; Rajaram R; Rice DC; Roth JA; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL
J Thorac Cardiovasc Surg; 2021 Nov; 162(5):1404-1412.e2. PubMed ID: 33010880
[TBL] [Abstract][Full Text] [Related]
22. The Impact of Signet Ring Cell Differentiation on Outcome in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma.
van Hootegem SJM; Smithers BM; Gotley DC; Brosda S; Thomson IG; Thomas JM; Gartside M; van Lanschot JJB; Lagarde SM; Wijnhoven BPL; Barbour AP
Ann Surg Oncol; 2019 Aug; 26(8):2375-2384. PubMed ID: 30941657
[TBL] [Abstract][Full Text] [Related]
23. Prognostic analysis of gastric signet ring cell carcinoma and mucinous carcinoma: a propensity score-matched study and competing risk analysis.
Tang CT; Chen Y; Zeng C
Aging (Albany NY); 2020 Nov; 12(21):22059-22077. PubMed ID: 33130635
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological characteristics of signet ring cell carcinoma of the stomach.
Kim DY; Park YK; Joo JK; Ryu SY; Kim YJ; Kim SK; Lee JH
ANZ J Surg; 2004 Dec; 74(12):1060-4. PubMed ID: 15574148
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological differences in signet ring cell adenocarcinoma between early and advanced gastric cancer.
Kao YC; Fang WL; Wang RF; Li AF; Yang MH; Wu CW; Shyr YM; Huang KH
Gastric Cancer; 2019 Mar; 22(2):255-263. PubMed ID: 30069742
[TBL] [Abstract][Full Text] [Related]
26. Applicability of endoscopic submucosal dissection for undifferentiated early gastric cancer: Mixed histology of poorly differentiated adenocarcinoma and signet ring cell carcinoma is a worse predictive factor of nodal metastasis.
Lee IS; Lee S; Park YS; Gong CS; Yook JH; Kim BS
Surg Oncol; 2017 Mar; 26(1):8-12. PubMed ID: 28317588
[TBL] [Abstract][Full Text] [Related]
27. Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis-a cohort study of 123 patients from a non-endemic country.
Zaafouri H; Jouini R; Khedhiri N; Khanchel F; Cherif M; Mesbahi M; Daghmouri A; Mahmoudi W; Akremi S; Sabbah M; Benzarti Y; Hadded D; Gargouri D; Bader MB; Maamer AB
World J Surg Oncol; 2022 Jul; 20(1):238. PubMed ID: 35858903
[TBL] [Abstract][Full Text] [Related]
28. Should Signet Ring Cell Histology Alter the Treatment Approach for Clinical Stage I Gastric Cancer?
Turgeon MK; Gamboa AC; Rupji M; Lee RM; Switchenko JM; El-Rayes BF; Russell MC; Cardona K; Kooby DA; Staley CA; Maithel SK; Shah MM
Ann Surg Oncol; 2021 Jan; 28(1):97-105. PubMed ID: 32524459
[TBL] [Abstract][Full Text] [Related]
29. Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: results of a multicentre retrospective study.
Honoré C; Goéré D; Messager M; Souadka A; Dumont F; Piessen G; Elias D; Mariette C;
Eur J Surg Oncol; 2013 Mar; 39(3):235-41. PubMed ID: 23313257
[TBL] [Abstract][Full Text] [Related]
30. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
[No Abstract] [Full Text] [Related]
31. Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the gallbladder.
Wang S; Li J; You J; Zhou Y
BMC Gastroenterol; 2021 Jun; 21(1):248. PubMed ID: 34090347
[TBL] [Abstract][Full Text] [Related]
32. Operable gastric adenocarcinoma with different histological subtypes: Cancer-specific survival in the United States.
Lin CL; Zhu GW; Huang YJ; Zheng W; Yang SG; Ye JX
Saudi J Gastroenterol; 2020; 26(1):46-52. PubMed ID: 32031158
[TBL] [Abstract][Full Text] [Related]
33. Surgically Managed Signet Ring Cell Esophageal Carcinomas in the National Cancer Database.
Sathe TS; Resio BJ; Hoag JR; Monsalve AF; Pathak R; Blasberg JD; Mase V; Dhanasopon A; Boffa DJ
Ann Thorac Surg; 2020 Jun; 109(6):1656-1662. PubMed ID: 32109449
[TBL] [Abstract][Full Text] [Related]
34. Advanced gastric carcinoma with signet ring cell histology.
Li C; Kim S; Lai JF; Hyung WJ; Choi WH; Choi SH; Noh SH
Oncology; 2007; 72(1-2):64-8. PubMed ID: 18004078
[TBL] [Abstract][Full Text] [Related]
35. [Skip metastasis at the esophageal resection margin in radical gastrectomy: clinical characteristics of 30 cases].
Liu S; Xia QY; Fu Y; Lu XF; Wang M; Guan WX
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):675-679. PubMed ID: 37583025
[No Abstract] [Full Text] [Related]
36. Signet ring cells in esophageal and gastroesophageal junction carcinomas have a more aggressive biological behavior.
Nafteux PR; Lerut TE; Villeneuve PJ; Dhaenens JM; De Hertogh G; Moons J; Coosemans WJ; Van Veer HG; De Leyn PR
Ann Surg; 2014 Dec; 260(6):1023-9. PubMed ID: 24836142
[TBL] [Abstract][Full Text] [Related]
37. Primary signet ring cell histology does not portend worse survival for early stage lung cancer following lobectomy.
Peng T; Yau A; Ding L; David EA; Wightman SC; Atay SM; Kim AW
Asian Cardiovasc Thorac Ann; 2022 Feb; 30(2):185-189. PubMed ID: 34549632
[TBL] [Abstract][Full Text] [Related]
38. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes of endoscopic submucosal dissection in comparison to surgery in undifferentiated-type intramucosal gastric cancer using propensity score analysis.
Park JC; Lee YK; Kim SY; Roh Y; Hahn KY; Shin SK; Lee SK; Lee YC; Kim HI; Cheong JH; Hyung WJ; Noh SH
Surg Endosc; 2018 Apr; 32(4):2046-2057. PubMed ID: 29052072
[TBL] [Abstract][Full Text] [Related]
40. The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study.
Messager M; Lefevre JH; Pichot-Delahaye V; Souadka A; Piessen G; Mariette C;
Ann Surg; 2011 Nov; 254(5):684-93; discussion 693. PubMed ID: 22005144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
